Pharmaco-proteogenomic profiling of pediatric diffuse midline glioma to inform future treatment strategies

Why are there no effective treatments for DIPG/DMG? The “tricky” nature of these tumours (their intra- and inter-variability), how this affects current gene-focused treatments, and the multimodal approach needed going forward, are outlined in the DunLab‘s latest article: “Pharmaco-proteogenomic profiling of pediatric diffuse midline glioma to inform future treatment strategies”.

Read more.